Results 231 to 240 of about 101,164 (260)

Mixed Invasive Adenoid Cystic and Lobular Carcinoma of the Breast: A Case Report of a Rare Hybrid Tumor. [PDF]

Cureus
Babker MS, Chavarria H.
europepmc   +1 more source

PIK3CA mutation detection by circulating tumor cell sequencing guides the effective PI3K inhibitor treatment of a patient with hormone receptor-positive breast cancer transformed into triple-negative breast cancer: A case report. [PDF]

Medicine (Baltimore)
Zhang J, Pei J, Hao G, Meng Y, Li F, Xu H, Liu H.   +6 more
europepmc   +1 more source

A bibliometric analysis of global research trends in adoptive cell therapy for triple negative breast cancer over the past 15 years. [PDF]

Discov Oncol
Elenien WIA, Ibrahim NA, Mohamed M, Elenien YA, Heiba M, Abouelenin O, Mahmood DA, Hussein FK.   +7 more
europepmc   +1 more source

Co-Pathogenic Role of BRCA1 and OBSCN Deletions in Chinese Familial Breast Cancer: A Case Report. [PDF]

Am J Case Rep
Yi L, Chen K, Wang D, Wang R, Zhu X, Chai J, Jia X, Xu F, Gu M, Cui C, Zhang W.   +10 more
europepmc   +1 more source

Lines Left Uncrossed: The Cost of Attrition in Metastatic Triple Negative Breast Cancer. [PDF]

Cureus
Devi R N, Krishnan M P A, Shenoy PK, Menon A.   +3 more
europepmc   +1 more source

Polygenic Risk Scores for Breast Cancer Among African American Women With High Risk.

JAMA Netw Open
Sun Y, Simmons T, Li JL, Jamal A, Manirakiza AVC, Pruss D, Ratzel S, Olopade OI, Gutin A, Hughes E, Huo D.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Investigation of the synergic effect of mocetinostat and capecitabine in a triple-negative breast neoplasms mouse model

Journal of Investigative Medicine
Combined administration of two or more drugs is emerging as a new strategy in triple-negative breast neoplasms. This is the first study to investigate the combination of the histone deacetylase inhibitor mocetinostat and the antimetabolite drug capecitabine in triple-negative mammary neoplasms in a preclinical mouse model.
Hacer Kaya Çakir, Onur Eroğlu
openaire   +5 more sources